ORAMED PHARMACEUTICALS INC. 8-K

What Happened

• Oramed Pharmaceuticals Inc. filed a Form 8-K on December 31, 2025 reporting that the Board received notice that director Leonard Sank intends to resign effective January 1, 2026.
• The filing states Mr. Sank served on the Company's board for 18 years and his resignation was not the result of any disagreement with the Company’s operations, policies, or practices.

Key Details

• Board received notice: December 31, 2025 (Form 8-K filed same day).
• Resignation effective date: January 1, 2026.
• Tenure: Leonard Sank served 18 years on the Board.
• Reason: Not due to any disagreement with the Company on operational, policy, or practice matters.

Why It Matters

• A board member departure is a governance change investors should note because it alters board composition and experience.
• The filing explicitly rules out a disagreement, which reduces immediate governance red flags; however, investors may watch for any announcement about a replacement or changes to committee assignments.
• For retail investors, this is primarily a corporate-governance update rather than an operational or financial development.